This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

In 2023-24, Wales received just £168m or 2% of the UK total, from UKRI – the body responsible for funding R&D and innovation

While attention has rightly focused on the financial crisis facing our universities, the growing instability across the sector poses another, less-discussed but potentially more damaging long-term threat: the risk to Welsh research capacity, innovation and the country’s wider economic future.

This matters because in a modern economy, research and innovation are among the key drivers of productivity, business creation and long-term prosperity. The countries and regions that generate ideas, develop intellectual property and turn discoveries into commercial activity are the ones that create the high-value jobs of the future. Those that do not are left behind, and that is precisely the danger Wales now faces.

READ MORE: We need a plan to revive and renew struggling universities in WalesREAD MORE: Welsh rugby makes a huge economic contribution shows new report

Across the UK, public investment in research and development remains substantial, but the way funding is allocated is increasingly favouring institutions with scale, critical mass, strong commercialisation records and the capacity to compete successfully at the highest level. In other words, the system increasingly rewards those universities and regions that are already ahead, and unfortunately, Wales is not included.

For over 20 years, I have maintained that research and innovation funding should be devolved, yet during that time, politicians have largely failed to make a compelling case, while too many vice-chancellors seem more comfortable defending the status quo than challenging it. The outcome is that Wales remains reliant on a UK-wide system that has consistently failed to reflect either our population share or our economic needs.

The numbers are stark. In 2023-24, Wales received just £168m or 2% of the UK total, from UKRI – the body responsible for funding R&D and innovation – despite accounting for around 5% of the UK population.

That shortfall is not a marginal issue but is a structural disadvantage with real economic consequences, and on a per-person basis, Wales received £53 compared with a UK average of £134, making Wales one of the weakest-funded parts of the UK both per head and as a share of GVA.

However, if research and development funding had been devolved and allocated through the Welsh fiscal framework, including a needs-based uplift, Wales could have received as much as £322m, almost double what it receives now.

Pause for a moment and consider that, over the past decade alone, Wales has missed out on more than £1bn of funding that could have boosted research capacity, innovation, business collaboration and the wider Welsh economy. This estimate is conservative because it does not account for the broader economic effects of greater control over R&D priorities, co-investment, commercialisation and regional innovation policy; the actual long-term loss to Wales could be higher.

Indeed, if this money had been available, it would have been transformational, providing more support for collaboration between universities and businesses and a greater scope to back commercially relevant innovation in sectors where Wales has genuine strengths. More importantly, it would have meant a far greater chance of turning Welsh ideas into Welsh wealth.

Too often, we talk about economic development in Wales as though it is mainly about grants, property schemes, infrastructure announcements or another reorganisation of the business support landscape. But if we are serious about creating a stronger economy, we need to pay much more attention to the sources of future value creation – research, innovation and commercialisation.

When research is strong, businesses benefit, new technologies emerge and intellectual property is developed and retained, while investors begin to look at a place differently, skills deepen and supply chains strengthen.

We already know what success can look like and Cardiff University’s Draig Therapeutics, which recently secured $140m in venture capital investment, is exactly the kind of example Wales should be producing more often. It shows what can happen when high-quality research, commercial focus and investor confidence come together.

However welcome one example may be, it is not enough. Wales should be building a pipeline of such businesses rather than celebrating them as rare exceptions. This is why the debate over research funding cannot be separated from the financial crisis currently affecting Welsh higher education. When universities fall into survival mode, research becomes vulnerable, particularly in institutions lacking large reserves, substantial endowments or a high level of research activity.

This damage is not easily reversed, and once research capacity begins to decline, rebuilding it is much more difficult than cutting it, as skilled teams disperse, international networks weaken and younger academics seek opportunities elsewhere. Consequently, commercial relationships drift apart, opportunities fade and, over time, the country’s ability to compete for talent, funding and investment diminishes.

This is why the stakes are so high. The issue is not simply whether Welsh universities can balance their books over the next two or three years, but whether Wales wants to remain a serious participant in the creation of new knowledge, new technologies and new industries.

At least there are signs that this argument is finally beginning to gain some political support. The First Minister recently stated that Wales should receive a fairer share of UK research funding, although there are no details on how she intends to achieve this. However, that recognition is welcome, even if it has taken more than a quarter of a century for the point to be taken seriously.

But fairer funding within the current system should not be the end of the debate, and Wales should be making the case for the full devolution of research and innovation funding. Properly designed and strategically deployed, it could do more to strengthen the long-term Welsh economy than almost anything the Welsh Government has undertaken in the field of economic development since devolution began.

That is why this matters so much, and the future of Welsh higher education is not only about keeping institutions afloat but about deciding whether Wales will be a country that creates knowledge, owns ideas and builds businesses from them, or one that watches others do so and wonders, once again, why the rewards end up elsewhere.

SUZUKA, Japan — Formula 1 heads to the revered Suzuka International Racing Course this weekend for the 2026 Japanese Grand Prix, the third round of a season already shaped by major technical regulation changes and Mercedes’ early dominance, with questions swirling about tyre management, energy deployment and whether challengers can disrupt the silver arrows’ stronghold.

The Japanese Grand Prix, traditionally one of the calendar’s most demanding tests, takes on added significance in 2026 as the first visit to Suzuka under the new formula. Teams and drivers will grapple with reduced downforce, altered power units and active aero systems on a circuit famous for its high-speed corners, figure-eight layout and punishing tyre demands.

As of late March 2026, Mercedes leads the constructors’ standings with 98 points, powered by strong performances from George Russell and rookie sensation Kimi Antonelli. Russell sits atop the drivers’ championship with 51 points, just ahead of teammate Antonelli on 47. Ferrari trails in second with 67 constructors’ points, led by Charles Leclerc and Lewis Hamilton.

2026 Regulations Reshape Suzuka Challenge

The 2026 rules have introduced smaller, lighter and more agile cars with significantly less downforce — reportedly around a 55% reduction in some areas — alongside new power unit specifications that place greater emphasis on electrical energy management. These changes promise closer racing in theory but have already exposed challenges in energy harvesting and deployment, particularly on circuits like Suzuka with long-duration corners and limited heavy braking zones.

Tyre strategy will be pivotal. Pirelli has brought its hardest compounds — C1, C2 and C3 — for the weekend. Historically, Suzuka’s high-speed Esses, Degner curves and Spoon Corner have inflicted heavy thermal degradation, often dictating a two-stop race. Under the new regs, the balance between front and rear axle demands could shift, potentially altering pit strategies and making one-stop attempts more viable or risky.

In a late tweak ahead of the weekend, the FIA reduced the maximum permitted energy recharge for qualifying from 9 megajoules to 8 MJ per lap. The adjustment aims to minimize excessive “lift-and-coast” tactics and energy management, ensuring drivers can push closer to the limit during the all-important session and improving the spectacle at a track where qualifying lap times matter immensely.

Additional circuit modifications, including fresh resurfacing on sections of the track and tweaks to active aero deployment (particularly approaching the high-speed 130R corner), could further influence car behavior and overtaking opportunities on the narrow, driver-focused layout.

Mercedes vs. Ferrari: Early Season Battle Intensifies

Mercedes has won both opening races of 2026, with Russell and Antonelli each claiming a victory. The team’s consistency and pace have set a high bar, but Suzuka — a circuit where Lewis Hamilton has enjoyed historic success — will test their adaptability to the new aero and power characteristics.

Ferrari arrives motivated after strong showings from Leclerc and Hamilton. The Scuderia sits second in constructors’ points and will look to exploit any weaknesses in Mercedes’ package around Suzuka’s flowing, high-commitment corners. Hamilton, returning to a track he knows intimately, could provide crucial feedback as the team fine-tunes its setup.

McLaren, the reigning constructors’ champions, has struggled so far with just 18 points. Lando Norris and Oscar Piastri will hope the technical demands of Suzuka play to their strengths, while Red Bull Racing — once dominant — sits fifth with only 12 points amid ongoing adaptation challenges for Max Verstappen and his teammates.

Emerging stories include Haas F1 Team’s impressive start (fourth in constructors with 17 points, thanks in part to Oliver Bearman) and the performances of young drivers like Antonelli and rookies such as Arvid Lindblad, who has already made headlines with bold qualifying runs.

Key Storylines and Predictions

Suzuka has long rewarded precision and bravery. With reduced downforce, cornering speeds through the S-curves may drop, potentially opening passing zones while increasing the importance of mechanical grip and tyre preservation. The figure-eight layout and elevation changes will amplify any handling imbalances caused by the new regulations.

Weather forecasts suggest cool conditions in the high teens Celsius, which could further influence tyre warm-up and degradation. Rain has often featured in Japanese Grands Prix, adding another layer of unpredictability.

Paddock talk centers on whether Mercedes can maintain its unbeaten streak or if Ferrari, McLaren or even surprise packages like Haas can mount a challenge. Analysts predict tight battles in qualifying, with Russell, Antonelli, Leclerc and Hamilton likely contending for pole. Verstappen, starting from lower grid positions in recent events, may need trademark recovery drives.

The weekend also marks the last race before a break, with the cancellation of Bahrain and Saudi Arabian rounds shifting focus to this high-stakes Japanese event.

Schedule and How to Follow

Practice sessions begin Friday, March 27, with FP1 and FP2 offering early clues on setup and tyre performance. Saturday features FP3 and qualifying, while the 53-lap race starts Sunday, March 29, at 14:00 local time (early morning in many international markets).

Fans can follow live on official F1 platforms, Sky Sports F1 and local broadcasters. Practice and qualifying highlights, along with post-session analysis, will be available shortly after each session.

Suzuka remains one of F1’s most beloved venues, blending raw driver skill with technical demands. In 2026, it serves as a critical early litmus test for the new regulations: Will the changes deliver the promised closer racing, or will they expose further teething problems that require mid-season adjustments?

As teams unpack at the Honda-owned circuit, the focus remains on extracting maximum performance from cars that look and behave differently from their 2025 predecessors. Mercedes enters as favorites, but history shows Suzuka rarely delivers predictable outcomes.

Whether a veteran like Hamilton adds to his Suzuka legacy, a young gun like Antonelli stamps his authority, or an underdog rises, the 2026 Japanese Grand Prix promises drama, high speeds through 130R and strategic battles that could reshape the championship narrative heading into the April break.

The markets traded under sustained pressure through the week, exhibiting a clear downward bias and ending on a negative note. The Nifty oscillated in a wide intra-week range of 994 points, moving between 23,465.35 and 22,471.25 before settling near the lower end of the range.Volatility surged further; the India VIX, which had already risen sharply in the previous week, extended its upmove and gained another ~17.5% on a weekly basis, reflecting heightened uncertainty. Despite this corrective phase, Indian equities continued to relatively outperform weaker global peers. The Nifty ended the week with a net loss of 294.90 points (-1.28%).

From a structural standpoint, the Nifty has violated and slipped below key short-term support levels, indicating a deterioration in the near-term trend. The index is now trading below its 50-week and 100-week moving averages and is approaching a critical support band.

The broader structure suggests a transition from consolidation to an extended corrective phase. With volatility expanding and prices weakening, the market remains vulnerable to further downside unless it swiftly reclaims lost levels.
Any pullbacks towards overhead resistance zones are likely to face selling pressure, while sustained trade below immediate supports may trigger an extended decline.
Given the truncated trading week, markets may begin on a cautious note with intermittent bouts of volatility. Immediate resistance levels are placed at 23,150 and 23,450, while supports come in at 22,450 and 21,700.The weekly RSI stands at 27.11, placing it in the oversold territory. While it has formed a 14-period low, it stays neutral and shows no visible bullish divergence against price, indicating continued weakness.
The MACD remains bearish and is positioned below its signal line, with momentum still negative. The formation of a strong bearish candle on the weekly chart reinforces the prevailing downside pressure.

Pattern analysis shows that the index has slipped below its short-to-medium-term moving averages, while the long-term 200-week moving average near 21,700 is now acting as a crucial support. The inability to hold above previous breakout zones suggests distribution at higher levels. The Index has dragged its overhead resistance levels lower as well.
Given the current setup, a cautious and defensive approach is strongly recommended for the coming week. Traders should avoid aggressive long positions and instead focus on capital preservation. Any rebound should be used more to lighten positions instead of initiating fresh exposure. A highly selective, stock-specific approach with strict risk management is advised while closely monitoring volatility trends.
In our look at Relative Rotation Graphs®, we compared various sectors against the CNX500 (NIFTY 500 Index), representing over 95% of the free-float market cap of all the listed stocks.

Relative Rotation Graphs (RRG) show that the Nifty PSE, Pharma, Energy, and Infrastructure Indices are inside the leading quadrant. They are likely to relatively outperform the broader markets. Metal, PSU, and the Financial Services groups are also inside this quadrant. While they may also relatively outperform, they are seen as giving up on their relative momentum against the broader markets.
The Nifty Bank Index has rolled inside the weakening quadrant. The Auto and the Midcap 100 Indices are also in this quadrant. However, the Midcap 100 Index is seen improving on its relative momentum.
The Nifty Services Sector Index has rolled inside the lagging quadrant. The Realty and the IT groups are also languishing inside this quadrant and may collectively underperform the broader Nifty 500 Index.

The Nifty Media and the FMCG Indices are inside the improving quadrant. Important Note: RRGTM charts show the relative strength and momentum of a group of stocks. In the above Chart, they show relative performance against the NIFTY500 Index (Broader Markets) and should not be used directly as buy or sell signals.

Apple’s iPhone 17e, released March 11, 2026, after a March 2 announcement, positions itself as the most affordable way to access the latest iOS features and Apple Intelligence at $599 for 256GB storage. Yet early reviews and consumer feedback highlight significant compromises that make it a questionable choice for many buyers just weeks after launch.

Priced the same as last year’s iPhone 16e but with incremental upgrades like MagSafe support, an A19 chip and doubled base storage, the iPhone 17e still lags behind the standard iPhone 17 and even some older models in key areas. Here are 10 compelling reasons why potential buyers should think twice before purchasing Apple’s latest entry-level smartphone.

1. It’s Not Really Budget-Friendly Anymore

At $599, the iPhone 17e carries a premium price tag for what many consider a mid-tier device. The final iPhone SE model launched at $429, and refurbished or discounted iPhone 15 units often sell for less while offering superior features in some categories. Critics argue that $599 no longer qualifies as “affordable” when flagship Android competitors deliver more hardware for similar or lower prices. The jump from previous SE pricing makes the “e” series feel like a marketing maneuver rather than genuine value.

2. Only a Single Rear Camera

The iPhone 17e sticks with just one 48MP rear camera, lacking an ultrawide lens found on the iPhone 17 and higher models. This limitation restricts versatility for landscape, group or macro photography. Reviewers note that while the main sensor performs adequately in good light, the absence of a secondary camera results in oddly cropped shots in certain scenarios and reduced creative options compared to virtually every modern mid-range competitor.

3. 60Hz Display Feels Outdated

Despite featuring a 6.1-inch OLED panel with Dynamic Island, the iPhone 17e remains locked at a 60Hz refresh rate. Smooth scrolling, gaming and general fluidity suffer compared to the 120Hz ProMotion displays on the iPhone 17 and Pro models. In 2026, many budget Android phones offer higher refresh rates, making the 17e’s screen feel dated for everyday use and gaming.

4. No Always-On Display

Users expecting modern conveniences will miss the always-on display capability available on higher iPhone models. The 17e cannot function as a bedside clock or glanceable notification hub without waking the screen, a small but noticeable downgrade in convenience that reviewers frequently cite as frustrating in daily use.

5. Binned A19 Chip with Reduced Performance

The iPhone 17e uses a binned or downclocked version of the A19 chip, featuring one fewer functional core than the full version in the standard iPhone 17. While still powerful enough for most tasks, this results in slightly lower peak performance and efficiency in demanding applications or future-proofing scenarios. The compromise feels particularly stingy given the phone’s price point.

6. Slower 15W MagSafe Charging

Although the addition of MagSafe is welcome after its absence on the 16e, the implementation caps at just 15W — significantly slower than the 25W available on recent flagship models. Wireless charging remains convenient for accessories but disappoints in speed, especially for users accustomed to faster options elsewhere in Apple’s lineup.

7. Limited Future-Proofing Compared to Flagships

With only a single camera, 60Hz screen and binned processor, the iPhone 17e risks feeling obsolete sooner than the iPhone 17 or Pro models. Software support will last several years thanks to Apple’s track record, but hardware limitations may hinder enjoyment of advanced Apple Intelligence features or future iOS updates that lean on better cameras and displays.

8. Better Alternatives Exist Within Apple’s Lineup

For just $200 more, buyers can step up to the standard iPhone 17, which offers a superior display, dual cameras, faster charging and the full A19 experience. Many analysts recommend skipping the 17e entirely and considering discounted previous-generation models or waiting for sales on higher-tier devices rather than settling for the entry-level option.

9. Compromised Camera and Selfie Experience

Beyond the single rear sensor, the front-facing camera setup trails behind recent iPhones. Reviewers report adequate but not exceptional low-light performance and limited versatility, making the 17e less ideal for social media users, content creators or anyone who values photography as a primary phone function.

10. Potential for Buyer’s Remorse in a Competitive Market

In a year when premium Android flagships and even mid-range options deliver higher refresh rates, multiple cameras and aggressive pricing, the iPhone 17e struggles to stand out. Early reviews describe it as “bad in a good way” — functional but full of frustrating compromises that leave many wondering if they should save for a better model or switch ecosystems. The phone serves older iPhone upgraders adequately but fails to excite new buyers or those seeking maximum value.

Weighing the Decision

The iPhone 17e does bring meaningful upgrades over the 16e, including MagSafe, more storage and a newer chip, and it supports full Apple Intelligence features. For users upgrading from very old devices who prioritize iOS simplicity and ecosystem integration, it may still make sense.

However, for most consumers in March 2026, the compromises — especially the display, camera system and pricing — tip the scales against purchase. Savvy shoppers should compare it directly against the iPhone 17, refurbished flagships or competitive Android options before committing.

Apple continues to refine its budget strategy with the “e” series, but the iPhone 17e illustrates the challenges of delivering a compelling experience at this price point without deeper cuts. As the device settles into the market, real-world user feedback will further clarify whether its strengths outweigh the listed drawbacks for individual needs.

Prospective buyers are advised to visit Apple Stores for hands-on testing and carefully evaluate their priorities around camera quality, display smoothness and long-term satisfaction before deciding.

Chris Hemsworth, the Australian actor who built a global empire as Marvel’s hammer-wielding Thor, is charting a more grounded path in 2026, trading Hollywood’s glare for family life in Australia while keeping one foot firmly in blockbuster territory.

The 42-year-old star recently called his decision to leave Los Angeles and raise his family back home “the greatest decision” he ever made, citing relentless paparazzi and the emptiness of a city where “nothing was shooting” during certain stretches of his career. Speaking on the “SmartLess” podcast while promoting his latest film, Hemsworth described how he and wife Elsa Pataky relocated after five years of marriage to escape the trappings of fame and give their three children a more normal upbringing.

“You’d come home to paparazzi,” Hemsworth recalled of his time in L.A. The move to Australia, he said, allowed him to travel for shoots without the constant intrusion, preserving both his sanity and his career momentum. The comments come as Hemsworth continues to balance high-profile projects with a deliberate focus on family and personal health.

Hemsworth and Pataky rang in the new year on a yacht in Sydney Harbour alongside his brother Liam Hemsworth and Liam’s fiancée Gabriella Brooks, sharing glimpses of a tight-knit family celebrating together. The low-key yet glamorous gathering reflected the actor’s preference for meaningful moments over red-carpet excess.

Professionally, 2026 has already delivered a major win with “Crime 101,” a star-studded heist thriller released in February that critics have hailed as “the first great movie of the year.” Hemsworth stars as an elusive jewel thief operating along Los Angeles’ 101 freeway, going against type in a more introverted, calculated role opposite Mark Ruffalo, Barry Keoghan and Halle Berry. Early reactions compared the film favorably to classics like “Heat” and “Collateral,” praising its tense pacing and strong ensemble performances. Hemsworth also served as a producer on the project.

The film’s success marks a strong start to the year for the actor, who continues to diversify beyond the Marvel Cinematic Universe while remaining one of its cornerstones.

On the superhero front, Hemsworth has confirmed he will reprise Thor in “Avengers: Doomsday,” set for release on Dec. 18, 2026, and has teased plans for the character beyond that tentpole. Appearing again on “SmartLess,” he revealed conversations with Marvel chief Kevin Feige about future appearances, saying he expects to play the God of Thunder “a couple more times.”

“I was talking to Kevin Feige about it, and he said it’s cool because the audience now expects dramatic turns with the character,” Hemsworth shared. “And whatever we do next — we’ve got some ideas to do something pretty unique again and hopefully be different.” The comments have fueled speculation about potential solo Thor projects or further evolution of the character, who has grown from a brash Asgardian to a more nuanced, comedic and dramatic figure across multiple films.

Hemsworth’s long association with the MCU, spanning 15 years by the time “Doomsday” arrives, shows no immediate signs of ending, even as he navigates personal reflections on vulnerability and legacy.

The actor has been candid about his genetic predisposition to Alzheimer’s disease, revealed during filming of the National Geographic series “Limitless.” Carrying two copies of the APOE4 gene significantly elevates his risk. In a recent interview with The Guardian, Hemsworth admitted initial worry that sharing his story might cause fans to “no longer believe” in him as an action star or Marvel hero.

“I wondered if I was letting people too far in,” he said. That openness extended to a deeply personal documentary, “A Road Trip to Remember,” in which Hemsworth and his father, Craig, who lives with Alzheimer’s, embark on a motorcycle journey across Australia to create lasting memories. The project highlights reminiscence therapy and family connection as tools for coping with the disease.

Hemsworth has made lifestyle adjustments in response, emphasizing physical and mental fitness, intermittent fasting and time with loved ones. He has spoken about how the diagnosis prompted him to prioritize presence over constant work, a shift that aligns with his move back to Australia.

Looking ahead, production on “Extraction 3” — the next installment in his popular Netflix action franchise — is slated to begin in June 2026, with filming running through October. The sequel will bring Tyler Rake’s story to Australia, with principal photography based in Sydney. The update comes nearly three years after the second film’s release, building anticipation for more of Hemsworth’s signature high-octane sequences shot closer to home.

Fans have also seen renewed interest in Hemsworth’s earlier work, with “Men in Black: International” — his 2019 team-up with Tessa Thompson — becoming available on Starz in January 2026.

Despite his global stardom, Hemsworth maintains a down-to-earth persona that resonates with audiences. His Centr fitness app and wellness brand continue to thrive, reflecting his commitment to health that now carries added personal significance. Industry observers note that his ability to blend blockbuster appeal with authentic vulnerability has only strengthened his standing in Hollywood.

The actor’s brothers, Liam and Luke Hemsworth, also remain active in entertainment, contributing to a family dynasty that has left its mark on screens worldwide. Chris has occasionally reflected on the unique dynamic of growing up in Australia and breaking into the industry together.

As awards season conversations continue and summer blockbuster planning ramps up, Hemsworth finds himself at an enviable crossroads: established icon with room for evolution. His upcoming slate suggests a mix of franchise obligations and passion projects, all while centering family in Byron Bay.

In interviews, Hemsworth has emphasized gratitude for his journey and a desire to make choices that serve both his career and his well-being. The move out of Los Angeles, he maintains, was not a retreat but a strategic realignment that has sustained his longevity in a demanding industry.

“Home is like a holiday,” he has said, underscoring the restorative power of returning to his roots.

With “Avengers: Doomsday” on the horizon and “Extraction 3” gearing up, 2026 promises to be another busy year for the star. Yet those closest to him say the real measure of success lies in the quiet moments — family gatherings, coastal life and the deliberate steps taken to protect his health and legacy.

As Marvel’s cinematic universe expands to incorporate new teams and threats, Hemsworth’s Thor remains a fan favorite whose future adventures could surprise even longtime viewers. Meanwhile, his willingness to discuss Alzheimer’s awareness has drawn praise from health advocates, turning personal challenge into public conversation.

Hemsworth’s story in 2026 is one of balance: wielding mythic power on screen while embracing ordinary joys off it. Whether swinging Mjolnir once more or stealing hearts in a gritty heist, the Australian export continues to prove that staying grounded can coexist with reaching new heights.

For fans tracking his every move, the message is clear — expect more Thor, more action and more of the thoughtful reflection that has defined his recent chapter. As Hemsworth himself might say with a trademark grin: the adventure is far from over.

MELBOURNE, Australia — Australian sprint sensation Gout Gout headlines one of the most anticipated domestic clashes of the 2026 athletics season Saturday night, racing rival Lachlan Kennedy in the men’s 200 meters at the Maurie Plant Meet, the opening World Athletics Continental Tour Gold event of the year.

The 18-year-old prodigy from Queensland arrives at Lakeside Stadium confident and healthy after battling illness at the recent state championships, declaring himself “ready to rock and roll” as he seeks revenge for last year’s narrow loss to Kennedy in the same Peter Norman Memorial 200m race.

Gout, widely regarded as one of the fastest teenagers in history and Australia’s brightest track prospect since Cathy Freeman, will line up against fellow Queenslander Kennedy — the defending champion who edged him in a thriller in 2025 — and Ireland’s Benjamin Richardson, a sub-20-second performer adding international spice to the marquee event. The race is scheduled for 9:21 p.m. AEDT.

Fresh off a dominant performance at the Queensland Athletics Championships earlier in March, where he claimed the open-age 200m title in 20.42 seconds despite a headwind and lingering sinus issues, Gout enters the meet as the clear favorite in the half-lap event he now calls his primary focus. He also won the under-20 100m title at the state meet, clocking 10.20 seconds (+1.5 wind) after shaking off a head cold that left him bed-ridden the previous day.

The teenager, who turned professional full-time after finishing Year 12 at Ipswich Grammar School late last year, has embraced the transition to elite-level training under coach Di Sheppard. Speaking to a swarm of media at Lakeside Stadium earlier this week, Gout appeared relaxed and stylish in his sponsor’s tracksuit, complete with earrings and chains, while expressing growing confidence.

“Confidence comes with experience,” he said, adding that the friendly but fierce rivalry with Kennedy has been “amazing” for pushing both athletes. “I’m the 200m specialist, so I’m just focusing on my 200 right now.”

Gout’s rapid rise has captivated Australia and drawn global attention. Born Dec. 29, 2007, the South Sudanese-Australian sprinter first exploded onto the scene in December 2024 when, at age 16, he shattered the long-standing Australian 200m record of 20.06 seconds set by Olympic silver medalist Peter Norman in 1968. His 20.04-second clocking at the Australian All Schools Championships not only broke that 56-year-old mark but established a world age best for under-17 athletes.

In February 2026, Gout opened his senior campaign in stunning fashion, equaling the fastest legal 100m time ever recorded by an Australian on home soil with a 10.00-second effort (+0.9 wind) at the Dane Bird-Smith Shield Meet in Brisbane. The performance demolished the previous Australian under-20 record and positioned him as the third-fastest Australian man in history over the distance, behind only Patrick Johnson and Rohan Browning.

That run also secured his first qualifying standard for the 2026 World Athletics Under-20 Championships in Eugene, Oregon, in August — the meet Gout has prioritized above all else this year. In a bold scheduling decision announced in February, he opted out of the 2026 Commonwealth Games in Glasgow to focus on claiming gold at the juniors, where he hopes to emulate Usain Bolt’s success as a teenager.

Gout’s 200m personal best stands at 20.02 seconds, making him the Australian record holder and one of the quickest half-lap runners of his generation worldwide. His progression has been meteoric: from 23.43 seconds as a 12-year-old to consistently dipping under 20.5 seconds while still a schoolboy.

The Maurie Plant Meet carries special significance as it honors Australian athletics administrator Maurie Plant and features the Peter Norman Memorial 200m, paying tribute to the 1968 Olympic silver medalist and human rights advocate. Last year’s edition saw Kennedy triumph in 20.26 seconds, with Gout close behind in what many described as an epic domestic battle.

Kennedy, a seasoned campaigner, set a new meet record in the 100m earlier Saturday evening with 10.03 seconds, signaling strong form heading into the 200m showdown. Richardson adds danger, having previously broken the 20-second barrier.

Gout has trained with Olympic 100m champion Noah Lyles in Florida during the off-season and plans a selective European campaign, including potential Diamond League appearances and the Ostrava Golden Spike meet in June. His manager and coach have carefully mapped a schedule designed to peak for the world juniors while building experience against senior competition.

Beyond raw speed, Gout’s appeal lies in his charisma and grounded personality. Viral clips of his races routinely rack up millions of views, with one 15-month-old heat performance recirculating widely on social media in recent days. Fans and pundits alike have drawn comparisons to Bolt, though Gout remains focused on his own path.

“I’m all clear, all healthy,” he told reporters Thursday, brushing off the sinus troubles that hampered his Queensland campaign. “I’m ready to rock and roll on Saturday.”

The Maurie Plant Meet marks the start of 12 Continental Tour Gold events in 2026, offering valuable ranking points and international exposure. Other Australian stars expected to shine include high jumper Nicola Olyslagers, pole vaulter Nina Kennedy and middle-distance runner Cameron Myers.

Australian Athletics officials have hailed Gout as a generational talent whose success could inspire a new wave of young sprinters, particularly from diverse backgrounds. His story — from a talented schoolboy to full-time professional chasing global glory — embodies the potential of the domestic talent pathway.

As evening falls on Lakeside Stadium, anticipation builds for what could be another chapter in one of Australian track’s most compelling rivalries. A victory for Gout would not only deliver redemption but also send a strong signal ahead of his international season.

Whether he dips under 20 seconds again or simply edges Kennedy in a photo finish, the teenage star’s presence ensures the meet will draw a capacity crowd and national television audience. For Gout Gout, Saturday night represents another step on the journey from schoolboy prodigy to senior superstar.

Fans can follow live results via Athletics Australia and World Athletics platforms. With the world under-20 championships on the horizon and whispers of future Olympic contention, the spotlight on Australia’s fastest teenager shows no signs of dimming.

The evening also underscores the depth of Australian sprinting, with multiple athletes capable of world-class performances on home soil. Yet all eyes remain fixed on Gout — the young man with the explosive start, powerful finish and unshakable belief that bigger things lie ahead.

As he prepares to toe the line once more, Gout Gout carries the hopes of a nation eager to see how far the teenager can fly in 2026 and beyond.

India’s heartbeat indices ended their two-session rally on Friday as a failure in the Iran-US negotiations even after one month, dampened the market mood. Elevated energy prices and a plunging rupee aggravated troubles for domestic investors. Markets were dragged mainly by financials, auto and consumer stocks amid high volatility. Nifty settled at 22,819.60, falling by 486.85 points or 2.09% while the BSE Sensex closed at 73,583.22, declining 1,690.23 points or 2.25%.

With just one more session to go in March, Nifty so far has plunged over 9% this month

Fear index India VIX settled at 26.80 on the NSE in the last session, up by 8.77%.

Analyst Sudeep Shah, Vice President and Head of Technical & Derivatives Research at SBI Securities, interacted with ETMarkets regarding the outlook for the Nifty and Bank Nifty, as well as an index strategy for the upcoming week. The following are the edited excerpts from his chat:

Q: The Israel-Iran war flipped the overall script in March which is seasonally a strong month as Nifty is down nearly 9%. Based on the F&O rollover data, what is your expectation for April?

Since the onset of the US–Iran war–led sell-off, one recurring pattern has consistently emerged in the markets. Short-lived pullbacks lasting 2–3 trading sessions have repeatedly been followed by sharp gap-down openings. Each of these brief rebounds has lured traders into a false sense of recovery, triggering FOMO-driven participation under the assumption that the worst is over. However, these pullbacks have consistently failed to sustain, and the optimism has quickly given way to fresh rounds of aggressive selling, often materializing as large gap-downs over the subsequent 2–3 trading sessions, making one question whether the next bounce is an opportunity or just another trap waiting to unfold.
This repetitive cycle of hope followed by sudden downside shocks is not only increasing volatility but is also leading to significant wealth erosion, particularly for short-term traders and leveraged positions. The inability of the market to build on pullbacks highlights the fragile sentiment and reinforces the need for caution, discipline, and risk management in the current environment because when conviction is missing, even small triggers can lead to disproportionately large reactions.
Month-to-date, the benchmark index Nifty has declined by over 9%, marking its steepest monthly fall since the Covid 19–induced market collapse. At the same time, disruptions in global gas supply are creating a diverse set of challenges across multiple industries, particularly those dependent on energy-intensive operations. These supply constraints have led to rising cost pressures, uncertainty around margins, and delayed investment decisions. Collectively, these factors are dampening hopes of an earnings revival and eroding overall market confidence, further weighing on investor sentiment and risk appetite—raising a deeper concern about whether the worst of the earnings downgrades is still ahead.
From a technical perspective, there has been no change since last week. The index continues to trade below its key moving averages, while momentum indicators remain firmly in bearish territory, indicating that downside pressure persists. Interestingly, the Nifty Midcap 100 and Nifty Smallcap 100 indices are displaying relative outperformance compared to the frontline indices. However, given the prevailing volatility and fragile sentiment, price action in the mid and smallcap space over the next 2–3 weeks to assess the sustainability of this relative strength because history suggests that leadership often shifts just when confidence starts to build.

Talking about crucial levels, the 22,650–22,600 zone is expected to act as an important support area for Nifty. A sustained break below 22600 could open the door for further downside, potentially dragging the index towards 22,400, followed by 22,200 in the short term. On the upside, the 23150–23200 region is likely to remain a critical resistance zone.

Q: Banks have been bleeding primarily because of FII outflows. Can you spot trading opportunities in Bank Nifty (or bank stocks) or at least suggest traders ways to cut their losses if more selling continues?

The banking benchmark index Bank Nifty has significantly underperformed the frontline indices during March. Month to date, the index is down by over 13% and has formed a sizeable bearish candle, highlighting strong selling pressure at higher levels. The ratio chart of the index as compared to Nifty is marking the sequence of lower tops and lower bottoms.

The weakness is further evident from the fact that the index is currently trading nearly 8% below its 200-day EMA and around 9% below its 100-day EMA, underscoring the loss of medium- to long-term trend support. From a momentum standpoint, the daily RSI has entered a super bearish zone as per RSI range shift rules, while the weekly RSI remains in bearish territory and continues to decline, indicating sustained downside momentum across timeframes.

Given the current price structure and negative momentum setup, the index is likely to extend its southward trajectory in the short term. In terms of key levels, the 51,700–51,800 zone is expected to act as an immediate support area. A sustained breakdown below 51,800 could result in further correction towards 51000, followed by 50,400 in the near term.

On the upside, any recovery attempt is likely to face strong resistance in the 53400–53500 zone, which will act as a major hurdle and supply area for the index.

Q: There is a bloodbath across situation and with Iran-Israel war uncertainty, it is very difficult to take an informed call. In such a situation, are you seeing themes/pockets of opportunities for investors?

The Nifty CPSE index is displaying relative outperformance compared to the broader and frontline indices. While the index has not shown strong bullish momentum, it is currently moving in a consolidation phase, even as the broader market undergoes a corrective decline. This relative resilience suggests better stability and selective accumulation, positioning Nifty CPSE as a comparatively stronger pocket amid an otherwise weak market environment.

Q: Unlike 2025, investors had a refuge in gold and silver and were putting money there. That situation has changed dramatically as we see bullion prices falling sharply. What will be your advice to investors whether to remain invested or preserve cash?

Market’s lackluster performance can be attributed to Nifty Bank, which has delivered its third worst performance in March in the past 20 years, declining by nearly 11%. What do bank Nifty charts suggest and how to trade?

Yes, the market’s lackluster performance has largely been driven by Bank Nifty, which has corrected by nearly 13%. This sharp underperformance has exerted significant pressure on the broader indices and weakened overall market sentiment.

Chart patterns of Bank Nifty continue to reflect a weak and bearish structure, indicating limited scope for a sustainable recovery in the near term. Given the prevailing trend and momentum setup, we recommend adopting a “sell on rise” strategy, as any short-term pullbacks are likely to remain corrective and may attract fresh selling pressure.

Q: For risk-takers, volatility brings opportunities for making money. Will you prefer cash markets or F&O?

Volatility is a double-edged sword. It creates opportunity, but also amplifies risk. For a risk-taker, the goal isn’t just to chase swings, but to manage them effectively. In volatile markets, moves are sharp and fast. If you’re right, profits can come quickly; if you’re wrong, losses can escalate just as rapidly. This is where the choice between cash and F&O becomes crucial.

F&O is a leveraged product, so volatility acts as a multiplier. If a trade goes against you, it becomes a double whammy. Price movement and leverage work against your capital. Even the right view can go wrong due to timing or sudden reversals. In contrast, cash markets offer better control. With proper position sizing and risk management, you can use volatility to your advantage without the pressure of leverage.

In such phases, it’s wiser to focus on survival first, because volatility rewards discipline, but punishes over-leverage.

Q: HEG, Emcure and Triveni Engineering were among top gainers this week, while Firstcry, IDBI Bank and Lodha have been big losers. What should investors do with them?

HEG had briefly slipped below its previous swing low of 491 on the daily chart but quickly reclaimed those levels, followed by an impressive rebound supported by a sharp rise in volumes. The DI+ crossing above DI- on the ADX indicator suggests that buyers are gaining control over sellers. As long as the stock holds above the 520–515 zone, the pullback is likely to extend further.

Emcure has witnessed a horizontal trendline breakout on the daily chart. The RSI is trending higher and sustaining above 60, indicating strong bullish momentum. Additionally, the DI+ crossover reinforces the dominance of buyers. The uptrend is likely to continue as long as the stock trades above 1580.

Triveni Engineering has staged a strong rebound from its key support zone of 335–325. The MACD has crossed above the signal line, indicating improving momentum. However, the stock faces stiff resistance around 418–420. A decisive breakout above this zone could lead to an extension of the pullback.

FirstCry has been consolidating in the 252–207 range since 19th February. The RSI failed to cross the 60 mark and has drifted lower, suggesting weakening momentum. The MACD remains below both the signal and zero line, indicating a bearish bias. The stock is likely to remain under pressure as long as it trades below 250.

Both IDBI Bank and Lodha are trading significantly below their key short- and long-term moving averages. A rising ADX indicates a strengthening bearish trend, while the RSI hovering around 20 reflects strong downside momentum. 72 for IDBI Bank and 760 for Lodha act as immediate resistance levels, and as long as the stocks trade below these levels, the trend is likely to remain bearish.

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)